News

Net profit of Kabra Drugs rose 171.79% to Rs 1.06 crore in the quarter ended March 2026 as against Rs 0.39 crore during the previous quarter ended March 2025. Sales reported to Rs 35.41 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.For the full year,net profit reported to Rs 4.96 crore in the year ended March 2026 as against net loss of Rs 1.09 crore during the previous year ended March 2025. Sales reported to Rs 92.74 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales35.410 0 92.740 0 OPM %3.780 -5.760 - PBDT1.440.40 260 5.80-1.08 LP PBT1.420.39 264 5.73-1.09 LP NP1.060.39 172 4.96-1.09 LP Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 6 May 2026.

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 21 April 2026.

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 7 March 2026.Powered by Capital Market - Live News